Has Navid Eghbalieh, MD received payments from drug or device companies?

Yes. Drug and device makers reported $639,454 in general payments to Navid Eghbalieh, MD across 710 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Navid Eghbalieh, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Navid Eghbalieh, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Navid Eghbalieh, MD

Vascular & Interventional Radiology · Los Angeles, CANPI 1497056105

Payments from drug & device makers

$639,454in general payments, 2019–2025

Across 710 payments — averaging $900.64 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Sirtex Medical Inc$393K
Terumo Medical Corporation$192K
Siemens Medical Solutions USA, Inc.$32K
Boston Scientific$9K
Varian Medical Systems, Inc.$8K
Medtronic$2K
plus $3K from 24 others

What the payments were for

Consulting fees$215,19434%
Speaking & faculty fees$371,85058%
Travel & lodging$33,9935%
Food & beverage$18,4173%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Sirtex Medical Inc	292	$393,262
Terumo Medical Corporation	187	$192,003
Siemens Medical Solutions USA, Inc.	39	$32,178
Boston Scientific	91	$9,073
Varian Medical Systems, Inc.	3	$7,875
Medtronic(3 entities)	53	$1,973
Penumbra, Inc.	7	$815
Balt USA, LLC	2	$339
Smith+Nephew	2	$255
Silk Road Medical, Inc.	8	$254
BD	2	$200
Bolton Medical Inc	1	$158
Baxter Healthcare	2	$141
Philips North America LLC	1	$128
Lemaitre Vascular, Inc.	1	$123
Covidien LP	1	$116
Argon Medical Devices, Inc.	1	$98
Shockwave Medical, Inc	1	$90
Integra Lifesciences Corporation	2	$60
Trisalus Life Sciences, Inc.	2	$45
Histosonics, Inc.	1	$44
Abbott	2	$42
Inspiremd Ltd	1	$32
Bard Peripheral Vascular, Inc.	2	$32
Olympus America Inc.	1	$25
Cardiovascular Systems Inc.	1	$20
Tactile Systems Technology Inc	1	$20
Blue Earth Diagnostics	1	$19
Amgen	1	$19
Teleflex LLC	1	$16

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

SIR-Spheres Microspheres$378,451
Azur CX Detachable$184,833
Navicross$47,991
GlideWire$35,243
GLIDESHEATH SLENDER$20,400
HydroPearl$17,755
Optitorque$10,200
Heartrail$10,200
LAVA LES (Liquid Embolic System)$9,641
MicroThermX Microwave Ablation System$8,138
GENERAL VASCULAR INTERVENTION$5,261
TR Band$2,748
Cryocare CS$2,494
GENERAL - THERAPIES$766
GENERAL - STENTS$714
Indigo System$545
AZUR$417
AngioSeal$376
Prestige Coil System$339
Valiant Captivia$309

How this compares

$639,454 in reported general payments places this provider in the 95th percentile of 504 vascular & interventional radiology providers in California.

See all vascular & interventional radiology providers in California →

Medicare billing

Part B allowed, 2024

$214,290

Medicare patients

2,670

Services billed

5,674

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Ondansetron OdtOndansetron	50	$605
Doxycycline Hyclate	54	$218
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen	17	$118
Ciprofloxacin Hcl	15	$41

Paid to pharmacies, not to this prescriber.

Other vascular & interventional radiology in Los Angeles

Keith TerasakiLos Angeles$1.7M
Edward LeeLos Angeles$1.7M
Siddharth PadiaLos Angeles$1.6M
Satoshi TateshimaLos Angeles$921K
John MoriartyLos Angeles$719K
Steven RamanLos Angeles$419K
Justin McWilliamsLos Angeles$355K
Jessica StewartLos Angeles$322K
Ravi SrinivasaLos Angeles$279K
Gary DuckwilerLos Angeles$237K

See the full list for California →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →